OCREVUS

Solution for injection, 920mg
RxActive license

Active substance (INN)

ocrelizumab

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength920mg
PackagingUkupno 1 bočica staklena sa 23ml rastvora za injekciju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG08)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateMay 29, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

OCREVUSRx
Concentrate for solution for infusion, 300mg/10mlF.Hoffmann-La Roche Ltd.
Source: CInMED register